Crossmark

Correction to: Bone Mineral Density During Treatment with The Janus Kinase Inhibitor Baricitinib in Patients with Rheumatoid Arthritis: A Monocentric Observational Study

Crossref DOI link: https://doi.org/10.1007/s00223-025-01451-0

Published Online: 2025-12-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schulz, Nils https://orcid.org/0009-0000-0378-3766
Asendorf, Thomas https://orcid.org/0000-0003-1317-2138
van Wijnen, Pascal https://orcid.org/0009-0007-2629-1837
Wilhelmi, Tim https://orcid.org/0009-0008-2400-2840
Müller-Ladner, Ulf https://orcid.org/0009-0000-8832-8112
Lange, Uwe https://orcid.org/0000-0001-7904-0619
Klemm, Philipp https://orcid.org/0000-0001-7911-4235
License Information

Text and Data Mining valid from 2025-12-05

Version of Record valid from 2025-12-05
More Information

Article History

First Online: 5 December 2025